Los Angeles Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

Los Angeles Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$547K	Buy	+43,137	New	+$490K	﹤0.01%	846
2022 Q2	–	Sell	-35,830	Closed	-$191K	–	1421
2022 Q1	$191K	Buy	35,830 +15,450	+76%	+$139K	﹤0.01%	1364
2021 Q4	$300K	Hold	20,380	–	–	﹤0.01%	1238
2021 Q3	$426K	Sell	20,380 -1,520	-7%	-$30.8K	﹤0.01%	1131
2021 Q2	$387K	Buy	+21,900	New	+$480K	﹤0.01%	1286

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Los Angeles Capital Management's ORIC Position: Q1 2026 in Review

Los Angeles Capital Management opened a new position in Oric Pharmaceuticals (ORIC) in Q1 2026: 43,137 shares worth $547K. The stake represents ﹤0.01% of the portfolio and ranks #846 among its holdings. This is a return to the name: Los Angeles Capital Management previously reported a position in ORIC as recently as Q1 2022.

Los Angeles Capital Management first reported a position in ORIC in Q2 2021 and has held it in 5 quarters since. 182 funds tracked by Wall St. Rank hold ORIC as of Q1 2026.

Los Angeles Capital Management held 43,137 shares of Oric Pharmaceuticals worth $547K as of Q1 2026.
Oric Pharmaceuticals was a new Los Angeles Capital Management position in Q1 2026.
Oric Pharmaceuticals made up ﹤0.01% of Los Angeles Capital Management's portfolio in Q1 2026, its #846 holding.
Los Angeles Capital Management first reported a position in Oric Pharmaceuticals in Q2 2021 and has held it in 5 quarters since.
182 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q1 2026.

Based on Los Angeles Capital Management's 13F filing for Q1 2026, filed 8 May 2026.